Syngenta AG (Syngenta AG) Total Current Assets : $11,744 Mil (As of Dec. 2018)

View and export this data going back to 1993. Start your Free Trial

What is Syngenta AG Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Syngenta AG's total current assets for the quarter that ended in Dec. 2018 was $11,744 Mil.

Syngenta AG Total Current Assets Historical Data

The historical data trend for Syngenta AG's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngenta AG Total Current Assets Chart

Syngenta AG Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Total Current Assets

Get a 7-Day Free Trial

11,565.00

11,198.00

11,356.00

12,059.00

11,744.00

Syngenta AG Semi-Annual Data
	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Total Current Assets	Get a 7-Day Free Trial															11,356.00	14,342.00	12,059.00	13,098.00	11,744.00

Syngenta AG Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Syngenta AG's Total Current Assets for the fiscal year that ended in Dec. 2018 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1889	+	4398	+	4292	+	1165
	=	11,744

Syngenta AG's Total Current Assets for the quarter that ended in Dec. 2018 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1889	+	4398	+	4292	+	1165
	=	11,744

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Syngenta AG (NYSE:SYT) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Syngenta AG's Liquidation Value for the quarter that ended in Dec. 2018 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1889	-	17048	+	0.75 * 4398	+	0.5 * 4292
=	-9,715

Syngenta AG Total Current Assets Related Terms

Thank you for viewing the detailed overview of Syngenta AG's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Syngenta AG (Syngenta AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Syngenta AG (NYSE:SYT) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Schwarzwaldalle 215, Basel, CHE, 4058

Website

http://www.syngenta.com

Formed in 2000 from spin-offs of Novartis' crop-protection and seeds business and AstraZeneca's agrochemical business, Syngenta is a global producer of crop chemicals and seeds. The Swiss company is a leading manufacturer of crop-protection products, making multiple herbicides, insecticides, and fungicides used on a wide variety of crops. Syngenta's seeds business trails rivals, but the company is investing heavily in research and development in an effort to close the technology gap in genetically modified seeds.